Nebius shares fall despite beating Q3 estimates By Investing.com
Nebius shares fall despite beating Q3 estimates By Investing.com Investing.com Nigeria
Covered in this story
Analyst targets on Nebius Group
- Rosenblatt Securities: at $221 · target $304 by Oct 2027 · Buy via TIKR.com
- BNP Paribas Exane: at $243 · target $399 by Sep 2027 · Outperform via finance.yahoo.com
- Bank of America: at $278 · target $310 by Aug 2027 · Buy via Yahoo Finance
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $NBIS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Nebius Group →Also covered by 1 other outlet
Dalsna Finance is currently tracking 50 stories mentioning Nebius Group, the earliest published 30 Jul 2026.
Summary aggregated from Investing.com Nigeria's public RSS feed. The full reporting belongs to Investing.com Nigeria — please read it on their site.